PRE-PEN
LOE Approachingbenzylpenicilloyl polylysine
BLAINJECTIONINJECTABLE
Approved
Jul 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRE-PEN is a benzylpenicilloyl polylysine injectable diagnostic agent used for penicillin allergy testing. It functions as a hapten-carrier conjugate that detects IgE antibodies to penicillin metabolites via intradermal skin testing. This agent enables clinicians to identify true penicillin-allergic patients and distinguish them from those with non-allergic adverse reactions.
LOE Approaching
Competitive pressure remains moderate (30/100), but LOE-approaching status signals declining commercial support and smaller marketing teams.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PRE-PEN offers limited career growth opportunities given its zero linked job count and LOE-approaching status. Roles are concentrated in niche diagnostic support, compliance, and operational management rather than high-visibility brand development or sales expansion.
Diagnostic Product ManagerMedical Science Liaison (Clinical Immunology)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.